Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies
Jing Zhou, Qing Ji, Qi Li
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
Anil Kumar, Vipasha Gautam, Arushi Sandhu, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 4, pp. 495-519
Open Access | Times Cited: 87
Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
William H. Gmeiner
Cancers (2024) Vol. 16, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 17
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort
Anwaar Saeed, Robin Park, Harsh B. Pathak, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
In vivo interaction screening reveals liver-derived constraints to metastasis
Costanza Borrelli, Morgan Roberts, Davide Eletto, et al.
Nature (2024) Vol. 632, Iss. 8024, pp. 411-418
Open Access | Times Cited: 15
Crucial Role of Oncogenic KRAS Mutations in Apoptosis and Autophagy Regulation: Therapeutic Implications
A I Ferreira, Flávia Pereira, Celso A. Reis, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2183-2183
Open Access | Times Cited: 42
Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
Samar Al Bitar, Marwan El‐Sabban, Samer Doughan, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 9, pp. 1395-1426
Open Access | Times Cited: 36
Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor
Yuesheng Zhang
Pharmacological Reviews (2023) Vol. 75, Iss. 6, pp. 1218-1232
Open Access | Times Cited: 31
The Warburg effect on radioresistance: Survival beyond growth
Hyunkoo Kang, Byeongsoo Kim, Junhyeong Park, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188988-188988
Closed Access | Times Cited: 31
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Xiangyu Sun, Ping Zhao, Jierou Lin, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 390-415
Open Access | Times Cited: 30
Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer
Zhengguang Li, Zhirong Yang, Wei Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 26
Anti‐angiogenesis in colorectal cancer therapy
Zhenni Yang, Xuqian Zhang, Xiaozhe Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 734-751
Open Access | Times Cited: 13
Inflammation and Colorectal Cancer: A Meta-Analysis of the Prognostic Significance of the Systemic Immune–Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)
Otília Menyhárt, János Tibor Fekete, Balázs Győrffy
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8441-8441
Open Access | Times Cited: 13
Targeting PI3K/AKT/mTOR Signaling to Overcome Drug Resistance in Cancer
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 8
Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cells
Yi‐Chiao Cheng, Ming‐Yao Chen, Vijesh Kumar Yadav, et al.
Translational Oncology (2025) Vol. 53, pp. 102274-102274
Closed Access | Times Cited: 1
Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia
Aldona Kasprzak
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3665-3665
Open Access | Times Cited: 16
Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer
Pashtoon Murtaza Kasi, Manuel Afable, Cameron J. Herting, et al.
The Oncologist (2023) Vol. 28, Iss. 12, pp. 1034-1048
Open Access | Times Cited: 16
Moringa oleifera Leaf Powder – Silver Nanoparticles (MOLP-AgNPs) efficiently inhibit metastasis and proliferative signaling in HT-29 human colorectal cancer cells
Hendra Susanto, Sa’diyatul Rizqie Amaliyah Firdaus, Moch. Sholeh, et al.
Journal of Agriculture and Food Research (2024) Vol. 16, pp. 101149-101149
Open Access | Times Cited: 6
RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review
Soukaina Benmokhtar, Abdelilah Laraqui, Farida Hilali, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access | Times Cited: 6
Signaling pathways in colorectal cancer implications for the target therapies
Yanlin Song, Ming Chen, Yuhao Wei, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy
Elena Richiardone, Rim Al Roumi, Fanny Lardinois, et al.
Cancer Letters (2024) Vol. 598, pp. 217091-217091
Open Access | Times Cited: 6
Metabolic Response to Small Molecule Therapy in Colorectal Cancer Tracked with Raman Spectroscopy and Metabolomics
Gabriel Cutshaw, Neeraj Joshi, Xiaona Wen, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 6
Nanomedicines for Overcoming Cancer Drug Resistance
Tingting Hu, Hanlin Gong, Jiayue Xu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1606-1606
Open Access | Times Cited: 26
Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer
Yanan Zheng, Siyue Lou, Jun Lu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 5
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7131-7131
Open Access | Times Cited: 4
Integrative Analysis of Transcriptomic Data Reveals a Predictive Gene Signature for Chemoradiotherapy Response in Rectal Cancer
Claudia Corro apos, Joao Victor Machado Carvalho, Melivoia Rapti, et al.
(2025)
Closed Access
Page 1 - Next Page

Scroll to top